Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

roval decisions for new drug applications by health authorities is an uncertain and evolving process and health authorities retain significant discretion at all stages of the regulatory review and approval decision process; (iv) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of the application of our technology platform to potential new drug candidates is therefore highly uncertain and unpredictable and one or more research and development programs could fail; (v) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (vi) the outcome of any existing or future intellectual property or other litigation related to our drug candidates and those of our collaboration partners.  Other important risks and uncertainties set forth in our Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2014. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.  Nektar Investor Inquiries: Jennifer Ruddock/Nektar Therapeutics

(415) 482-5585Susan Noonan/SA Noonan Communications, LLC

(212) 966-3650Nektar Media Inquiries:
Jodi Sievers/Nektar Therapeutics(415) 482-5593 NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(Unaudited)ASSETSJune 30, 2014Dece
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is ... Inc. ("Vitae" or the "Company") (NASDAQ: VTAE ... S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ... and certain of its officers and/or directors have violated ... of 1934.  On February 27, 2015, ...
(Date:2/27/2015)...  Pharmacyclics, Inc. (NASDAQ: PCYC ) ... in the Proceedings of the National Academy ... when ibrutinib (IMBRUVICA ® ) was combined with ... tumor growth was enhanced suggesting a greater response ... and solid tumors with the combination. IMBRUVICA is ...
(Date:2/27/2015)...  Acsis Inc., the market leader for supply chain ... John DiPalo , Acsis, Chief Strategy Officer, has ... Executive 2015 Provider Pro to Know. The award ... help prepare their companies, and customers, supply chains for ... list of Provider Pros to Know is featured in ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
... AcelRx Pharmaceuticals, Inc. announced today that results ... of its oral transmucosal NanoTab(TM) formulation of sufentanil ... the upcoming American Society of Anesthesiologists Annual Meeting ... Officer of AcelRx, will present in the following ...
... Oct. 15 Azopharma Product Development Group, LLC, ... services and PharmaNet Development Group, Inc., a leading ... biotechnology, generic drug and medical device companies, are ... development and co-promotion alliance to leverage complementary services, ...
Cached Medicine Technology:Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance 2
(Date:2/27/2015)... Cary, NC (PRWEB) February 27, 2015 ... nation’s leading cancer research funding organizations, is excited to ... varied ways to participate and many long-standing partnerships highlight ... cancer and focus on expanding ways for all to ... cash donations to cutting-edge cancer research, The V Foundation ...
(Date:2/27/2015)... The federal court overseeing more than ... of the statin medication can increase a person’s risk ... order pertaining discovery in the cases selected for the ... The Order, which was issued in the U.S. District ... the parties to schedule certain witness depositions before May ...
(Date:2/27/2015)... Royal River Natural Foods, a locally-owned independent natural ... found adults who got the most magnesium were less than ... those who got the least magnesium, with the largest benefit ... is part of the March 2015 issue of “ Natural ... publishes free each month for the Freeport community to learn ...
(Date:2/27/2015)... Wisconsin (PRWEB) February 27, 2015 Dr. ... plastic surgeons , is pleased to announce the expansion ... now open in Delafield. Quintessa has begun seeing patients ... the new Delafield location will offer a variety of ... including: Botox, filler injectables, micro laser peels, chemical peels, ...
(Date:2/27/2015)... Chicago, IL (PRWEB) February 27, 2015 ... at Lutheran General Hospital on June 25, 2013 and ... into her stomach through her mouth. Because the ... became infected with the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). ... the Circuit Court of Cook County on behalf of ...
Breaking Medicine News(10 mins):Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 2Health News:The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2
... Cards Celebrates its 50th anniversary this holiday season, ... of nonprofit,Minneapolis-based Courage Center, announces its new 2008 ... season, Courage Cards is,celebrating its 50th anniversary as ... to announce our 2008 Courage Cards artists:, ...
... (NYSE:,CNO) will host a conference call to discuss ... at 10:00 a.m. Eastern Daylight,Time., On August ... a more,detailed description of the company,s investment portfolio ... this supplement can be accessed through the Investors ...
... 8 The U.S. Department of,Veterans Affairs (VA) ... veterans, voter registration activities, with particular focus on,inpatients ... and,patients with limited access to community voter registration ... local election officials and,non-partisan groups to its hospitals ...
... gene therapy at the University of Florida to treat a ... vision, according to a paper published online today in ... and two men ranging from 21 to 24 years old ... type 2 volunteered to test the safety of an ...
... Collaborative of major health plans launches online toolkit ... in health care, WASHINGTON, Sept. 8 ... toolkit of resources, lessons, case,studies and videos to ... memberships., The Collaborative brings together 11 major ...
... Parents probably,wouldn,t have guessed, but kids like soyfoods. ... soyfoods as much as meat,counterparts. The trick -- ... soyfoods., A plate waste study, funded by ... macaroni & cheese, burgers, chicken nuggets, and,chicken Caesar ...
Cached Medicine News:Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:Conseco Announces Call on Investment Portfolio Supplement 2Health News:VA Clarifies Voter Registration Regulations 2Health News:Safety study indicates gene therapy for blindness improves vision 2Health News:Safety study indicates gene therapy for blindness improves vision 3Health News:National Health Plan Collaborative Launches Online Toolkit to Assist Health Plans in Reducing Disparities 2Health News:Back to School With Soy 2
... Hip Stabilizer Abduction and ... replacements, revisions and fractures. ... abduction with adjustable flexion ... settings. Adjustabelt back panel. ...
... low cost walker features a non-skid rocker ... low profile design minimizes leg length discrepancies. ... makes strapping quick and easy. Steel uprights ... swollen ankles and extra bandaging. This extra ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... Walker is a short pneumatic walking brace ... Because of its shorter height it is ... calf circumference prohibits them from using a ... for patient comfort while providing superior injury ...
Medicine Products: